ClinicalTrials.Veeva

Menu

Orsiro™ Drug Eluting Stent in Routine Clinical Practice (IRIS ORSIRO)

S

Seung-Jung Park

Status

Completed

Conditions

Coronary Artery Disease
Angioplasty, Transluminal, Percutaneous Coronary

Treatments

Device: Orsiro™ Drug Eluting Stent group

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT02039739
AMCCV2014-02

Details and patient eligibility

About

The purpose of this study is to evaluate effectiveness and safety of Orsiro™ Drug Eluting Stent in Routine Clinical Practice

Enrollment

1,007 patients

Sex

All

Ages

20+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 20 and more
  • Intervention with Orsiro™ Drug Eluting Stent
  • Agreed with written informed consent form

Exclusion criteria

  • Intervention with Orsiro™ drug eluting coronary stent and other drug eluting stent at the same time
  • Life expectancy of 1year and under
  • Cardiac shock

Trial design

1,007 participants in 1 patient group

Orsiro™ Drug Eluting Stent
Treatment:
Device: Orsiro™ Drug Eluting Stent group

Trial contacts and locations

18

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems